These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8743289)

  • 1. Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library.
    Richter W; Northemann W; Müller M; Böhm BO
    Hybridoma; 1996 Apr; 15(2):103-8. PubMed ID: 8743289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
    Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
    J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
    Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
    Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling.
    Myers MA; Davies JM; Tong JC; Whisstock J; Scealy M; Mackay IR; Rowley MJ
    J Immunol; 2000 Oct; 165(7):3830-8. PubMed ID: 11034389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
    Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
    Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate decarboxylase-derived IDDM autoantigens displayed on self-assembled protein nanoparticles.
    Choi H; Ahn JY; Sim SJ; Lee J
    Biochem Biophys Res Commun; 2005 Feb; 327(2):604-8. PubMed ID: 15629156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
    Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
    J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
    Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
    J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
    Teoh KL; Fida S; Rowley MJ; Mackay IR
    Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.